A leading specialist in medically supervised alcohol reduction says moderate wine consumption this Christmas could actually ...
Global Population Health Management Market OverviewThe global population health management (PHM) market is on a strong growth trajectory, projected to expand at a CAGR of 15–17% over the next five ...
The global microplate systems market is projected to grow at a compound annual growth rate (CAGR) of approximately 4% over ...
The global intravenous (IV) fluid bags market is projected to grow at a compound annual growth rate (CAGR) of approximately 6 ...
The global pressure monitoring market is anticipated to expand at a compound annual growth rate (CAGR) of around 8% during ...
Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line[1] Data ...
The global long-term care (LTC) market is projected to grow at a CAGR of 6–8% over the next five years, reflecting increasing demand for sustained healthcare support across aging populations worldwide ...
IntroductionThe global teleradiology market is experiencing rapid expansion, fueled by the growing need for remote diagnostic capabilities, rising digitalization of healthcare, and the increasing ...
Feedback from U.S. Food and Drug Administration (FDA) supports advancement into a pivotal Phase 3 trial and a 505(b)(2) regulatory pathway Phase 3 SURPASS-IPF trial remains on track to be initiated by ...
ENIGMA-TRS 2 is a global, randomized, double-blind, placebo-controlled 12-week Phase III clinical study designed to enroll at least 400 patients; topline results are expected by Q4 2026Evenamide is a ...
Oslo, Norway, 8 December 2025 - Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced the publication of 12-month data from its ...
Pan Cancer T B.V., a biotech company pioneering next-generation T cell therapies for solid tumours, today announced a EUR 10 million financing to advance its lead program, PCT1:CO-STIM, into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results